Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
THOR Photomedicine is a leading medical device company specializing in the development and manufacture of Photobiomodulation (PBM) therapy systems, formerly known as Low-Level Laser Therapy (LLLT). The company's technology utilizes specific wavelengths of red and near-infrared light to stimulate cellular function, reduce inflammation, and promote tissue repair by targeting mitochondrial cytochrome c oxidase. THOR's products are widely used by professional sports teams, hospitals, and clinics globally for indications such as chronic pain management, wound healing, and the treatment of oral mucositis. With a strong emphasis on evidence-based practice, the company collaborates extensively with researchers and has contributed to numerous peer-reviewed studies. Their product line includes handheld laser probes, LED clusters, and whole-body light pods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thor Laser.